IDH2 and oligodendroglioma: The current definition of oligodendrogliomas requires the presence of an IDH mutation combined with a 1p/19q codeletion [13], and therefore, the inclusion criteria of previous studies and clinical trials, when based on histological diagnosis, would not be valid nowadays.